Back to results
US 2013/0259901 A1Published application
Neuropeptide Y Treatment of Autoimmune Disease
OwnerStaley A. Brodinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating or delaying the onset of an autoimmune condition in a human subject comprising orally administering to the subject at an effective dose of neuropeptide Y.
Claims18
A method for treating or delaying the onset of multiple sclerosis or type 1 diabetes in a subject comprising the step of:
- orally administering to the subject an effective dose of neuropeptide Y.
(canceled)
A method for treating or delaying the onset of multiple sclerosis or type 1 diabetes in a subject by decreasing innate inflammatory cytokines IL-1β and TNF-α, Th1-like cytokines IL-2 and IFN-γ, IL-17 (Teff), IL-12p70 and increasing the Th2-like counter-regulatory cytokine IL-13 comprising the step of:
- orally administering to the subject an effective dose of neuropeptide Y.
(canceled)
Dependencies are inferred from the claim text.